In Brief: Abbott Gabitril
Executive Summary
Abbott Gabitril: Tiagabine is "approvable" as of Oct. 31. Abbott filed the NDA for the anticonvulsant as an adjuvant therapy for partial seizures on Nov. 3, 1995. The company has also completed Phase III trials of Gabitril as a monotherapy...